Radiopharmaceutical Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Report ID: 1692 | Published Date: Sep 2024 | No. of Page: 97 | Base Year: 2023 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents
1  RESEARCH SCOPE
    1.1 Research Product Definition
    1.2 Research Segmentation
        1.2.1 Product Type
        1.2.2 Main product Type of Major Players
    1.3 Demand Overview
    1.4 Research Methodology
2 GLOBAL RADIOPHARMACEUTICAL INDUSTRY
    2.1 Summary about Radiopharmaceutical Industry
    2.2 Radiopharmaceutical Market Trends
        2.2.1 Radiopharmaceutical Production & Consumption Trends
        2.2.2 Radiopharmaceutical Demand Structure Trends
    2.3 Radiopharmaceutical Cost & Price
3  MARKET DYNAMICS
    3.1 Manufacturing & Purchasing Behavior in 2020
    3.2 Market Development under the Impact of COVID-19
        3.2.1 Drivers
        3.2.2 Restraints
        3.2.3 Opportunity
        3.2.4 Risk
4  GLOBAL MARKET SEGMENTATION
    4.1 Region Segmentation (2017 to 2021f)
        4.1.1 North America (U.S., Canada and Mexico)
        4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
        4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
        4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
        4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
    4.2 Product Type Segmentation (2017 to 2021f)
        4.2.1 SPECT Radioisotopes
        4.2.2 PET Radioisotopes
        4.2.3 Other Diagnostic Radioisotopes
        4.2.4 Therapeutic Radioisotopes
    4.3 Consumption Segmentation (2017 to 2021f)
        4.3.1 Oncology
        4.3.2 Cardiology
        4.3.3 Others
5  NORTH AMERICA MARKET SEGMENT
    5.1 Region Segmentation (2017 to 2021f)
        5.1.1 U.S.
        5.1.2 Canada
        5.1.3 Mexico
    5.2 Product Type Segmentation (2017 to 2021f)
        5.2.1 SPECT Radioisotopes
        5.2.2 PET Radioisotopes
        5.2.3 Other Diagnostic Radioisotopes
        5.2.4 Therapeutic Radioisotopes
    5.3 Consumption Segmentation (2017 to 2021f)
        5.3.1 Oncology
        5.3.2 Cardiology
        5.3.3 Others
    5.4 Impact of COVID-19 in North America
6  EUROPE MARKET SEGMENTATION
    6.1 Region Segmentation (2017 to 2021f)
        6.1.1 Germany
        6.1.2 UK
        6.1.3 France
        6.1.4 Italy
        6.1.5 Rest of Europe
    6.2 Product Type Segmentation (2017 to 2021f)
        6.2.1 SPECT Radioisotopes
        6.2.2 PET Radioisotopes
        6.2.3 Other Diagnostic Radioisotopes
        6.2.4 Therapeutic Radioisotopes
    6.3 Consumption Segmentation (2017 to 2021f)
        6.3.1 Oncology
        6.3.2 Cardiology
        6.3.3 Others
    6.4  Impact of COVID-19 in Europe
7  ASIA-PACIFIC MARKET SEGMENTATION
    7.1 Region Segmentation (2017 to 2021f)
        7.1.1 China
        7.1.2 India
        7.1.3 Japan
        7.1.4 South Korea
        7.1.5 Southeast Asia
        7.1.6 Australia
        7.1.7 Rest of Asia Pacific
    7.2 Product Type Segmentation (2017 to 2021f)
        7.2.1 SPECT Radioisotopes
        7.2.2 PET Radioisotopes
        7.2.3 Other Diagnostic Radioisotopes
        7.2.4 Therapeutic Radioisotopes
    7.3 Consumption Segmentation (2017 to 2021f)
        7.3.1 Oncology
        7.3.2 Cardiology
        7.3.3 Others
    7.4  Impact of COVID-19 in Europe
8  SOUTH AMERICA MARKET SEGMENTATION
    8.1 Region Segmentation (2017 to 2021f)
        8.1.1 Brazil
        8.1.2 Argentina
        8.1.3 Rest of Latin America
    8.2 Product Type Segmentation (2017 to 2021f)
        8.2.1 SPECT Radioisotopes
        8.2.2 PET Radioisotopes
        8.2.3 Other Diagnostic Radioisotopes
        8.2.4 Therapeutic Radioisotopes
    8.3 Consumption Segmentation (2017 to 2021f)
        8.3.1 Oncology
        8.3.2 Cardiology
        8.3.3 Others
    8.4  Impact of COVID-19 in Europe
9  MIDDLE EAST AND AFRICA MARKET SEGMENTATION
    9.1 Region Segmentation (2017 to 2021f)
        9.1.1 GCC
        9.1.2 North Africa
        9.1.3 South Africa
        9.1.4 Rest of Middle East and Africa
    9.2 Product Type Segmentation (2017 to 2021f)
        9.2.1 SPECT Radioisotopes
        9.2.2 PET Radioisotopes
        9.2.3 Other Diagnostic Radioisotopes
        9.2.4 Therapeutic Radioisotopes
    9.3 Consumption Segmentation (2017 to 2021f)
        9.3.1 Oncology
        9.3.2 Cardiology
        9.3.3 Others
    9.4  Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
    10.1 Brief Introduction of Major Players
        10.1.1 Bayer
        10.1.2 Triad Isotopes
        10.1.3 Lantheus
        10.1.4 GE Healthcare
        10.1.5 Mallinckrodt
        10.1.6 Eli Lilly
        10.1.7 Bracco Imaging
        10.1.8 SIEMENS
        10.1.9 Navidea
        10.1.10 Nordion
        10.1.11 IBA Group
        10.1.12 Jubilant Pharma
    10.2  Radiopharmaceutical Sales Date of Major Players (2017-2020e)
        10.2.1 Bayer
        10.2.2 Triad Isotopes
        10.2.3 Lantheus
        10.2.4 GE Healthcare
        10.2.5 Mallinckrodt
        10.2.6 Eli Lilly
        10.2.7 Bracco Imaging
        10.2.8 SIEMENS
        10.2.9 Navidea
        10.2.10 Nordion
        10.2.11 IBA Group
        10.2.12 Jubilant Pharma
    10.3  Market Distribution of Major Players
    10.4 Global Competition Segmentation
11  MARKET FORECAST
    11.1  Forecast by Region
    11.2  Forecast by Demand
    11.3  Environment Forecast
        11.3.1  Impact of COVID-19
        11.3.2  Geopolitics Overview
        11.3.3  Economic Overview of Major Countries
12  REPORT SUMMARY STATEMENT
List of Table
1.Table Radiopharmaceutical Product Type Overview
2.Table Radiopharmaceutical Product Type Market Share List
3.Table Radiopharmaceutical Product Type of Major Players
4.Table Brief Introduction of Bayer
5.Table Brief Introduction of Triad Isotopes
6.Table Brief Introduction of Lantheus
7.Table Brief Introduction of GE Healthcare
8.Table Brief Introduction of Mallinckrodt
9.Table Brief Introduction of Eli Lilly
10.Table Brief Introduction of Bracco Imaging
11.Table Brief Introduction of SIEMENS
12.Table Brief Introduction of Navidea
13.Table Brief Introduction of Nordion
14.Table Brief Introduction of IBA Group
15.Table Brief Introduction of Jubilant Pharma
16.Table Products & Services of Bayer
17.Table Products & Services of Triad Isotopes
18.Table Products & Services of Lantheus
19.Table Products & Services of GE Healthcare
20.Table Products & Services of Mallinckrodt
21.Table Products & Services of Eli Lilly
22.Table Products & Services of Bracco Imaging
23.Table Products & Services of SIEMENS
24.Table Products & Services of Navidea
25.Table Products & Services of Nordion
26.Table Products & Services of IBA Group
27.Table Products & Services of Jubilant Pharma
28.Table Market Distribution of Major Players
29.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
30.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
31.Table Global Radiopharmaceutical Market Forecast (Million USD) by Region 2021f-2026f
32.Table Global Radiopharmaceutical Market Forecast (Million USD) Share by Region 2021f-2026f
33.Table Global Radiopharmaceutical Market Forecast (Million USD) by Demand 2021f-2026f
34.Table Global Radiopharmaceutical Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
1.Figure Global Radiopharmaceutical Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Radiopharmaceutical Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Radiopharmaceutical Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Radiopharmaceutical Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Radiopharmaceutical Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Radiopharmaceutical Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Radiopharmaceutical Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure SPECT Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure PET Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Other Diagnostic Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Therapeutic Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Cardiology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure SPECT Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure PET Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Other Diagnostic Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Therapeutic Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Cardiology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure SPECT Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure PET Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Other Diagnostic Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Therapeutic Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Cardiology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure SPECT Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure PET Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Other Diagnostic Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Therapeutic Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Cardiology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure SPECT Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure PET Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Other Diagnostic Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Therapeutic Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Cardiology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure SPECT Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure PET Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
72.Figure Other Diagnostic Radioisotopes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
73.Figure Therapeutic Radioisotopes Segmentation Market Size (USD Million) 2017
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Radiopharmaceutical Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Radiopharmaceutical Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Radiopharmaceutical Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports